What is anisomycin?
Anisomycin is a biological compound naturally produced by some bacteria Streptomyces . It disrupts protein synthesis in a number of organisms and has potential clinical applications in many areas. One area where it is not effective is the treatment of bacterial infections. This compound is primarily used in laboratory environments and has not been produced by synthetic means since 2011, although scientists have experimented with synthesis methods to form this compound in more reliable and large concentrations.
Inhibition of protein can prevent DNA expression. Protozoans and mushrooms are susceptible to the compound, and when scientists originally discovered it in the 1950s, it was designed for use against these infectious agents. In the laboratory, scientists can use anisomycin in experiments where they want to be able to inhibit DNA synthesis for activities such as insulation of living organisms in culture. Laboratory suppliers by lines of biological compounds sell anisomycin intended for laboratoryAtory use through your catalogs. The final preparation is not intended for medical use in humans or animals and is sold with marking clearly indicating that it can only be used in a laboratory environment. Legal restrictions may also require laboratories to enroll in purchase requests and have caution in the distribution of the compound to make sure it is not used inappropriately, as this could create a security problem.
In human research, anisomycin has two potential applications. One is like a psychiatric drug because it seems to be active in some parts of the brain. In particular, anisomycin may disrupt the synthesis of protein in amygdale, potentially dulling the reaction of fear, and helping people manage traumatic or upsetting memories. The drug may also be active against cancer, as it can focus on replication of cancer DNA and prevent it from proliferating and stopping tumor growth.
Like other biological compounds, anisomycin is the topic of interest for scientists who want to develop new medical treatment and laboratory techniques. The process of converting biologically active compounds into a commercially useful pharmacist can take a very long time, because scientists must be able to reliably produce a compound, find out what it does, and determine whether it is safe for use in humans. This process may conclude that the compound has no medical applications.